GHRS GH Research PLC
GHRS GH Research PLC
Healthcare · Biotechnology
Desk view
Market read
POC $14.87 · VWAP $19.65 · -7.6% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 watchlist
GHRS Price Structure
Loading timeframes…
Peers
Every watchlist GHRS belongs to, members best 30-day change first — GHRS highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Reported EPS $-0.23 versus analyst consensus of $-0.30 (+24.2%).
full note →Against street estimates
How GHRS's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Recent news
Headlines about GHRS from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 3 days ago · Oct 14
- GHRS: GH Research PLC Stock Price Quote - NASDAQ GM - Bloomberg
- GH Research Reports Second Quarter 2026 Financial Results and Provides Business Update | GH Research
- GH Research (GHRS) Q2 2026 Earnings Results & Report - MarketBeat
- GH Research Reports Full Year 2025 Financial Results and Provides Business Update
- GH Research Reports First Quarter 2026 Financial Results and Provides Business Update
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
GHRS research tape
24 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.